Lillian E. Ekem
-
Assessment of Hedgehog/GLI2 signaling inhibitors within metastatic breast cancers
Hedgehog pathway inhibitors were established as potential remediation treatments for tumor-induced bone disease. Additionally, hypotheses concerning inhibition methods were established for future investigation.